Literature DB >> 26868914

Emotional Consequences of Finasteride: Fool's Gold.

Christine Anne Ganzer1, Alan Roy Jacobs1.   

Abstract

Androgenetic alopecia, the gradual, progressive loss of hair frequently results in psychological despair, in part related to changes in self-image. Current androgenetic alopecia treatments are limited to hair transplantation and medications that inhibit dihydrotestosterone, a potent androgen associated with follicular micronization. Users of finasteride, which prevents dihydrotestosterone production, report serious physical and emotional adverse effects, collectively known as post-finasteride syndrome. Psychiatric illnesses and personality traits, specifically neuroticism influence emotional well-being. Limited research exists exploring the psychological corollaries of post-finasteride syndrome and preexisting Axis I and Axis II mental health conditions. The aim of this study was to explore how having a preexisting personal and/or familial history of a psychiatric diagnosis and certain personality traits may influence anxiety and depression among finasteride users. Participants in this online survey completed the Beck Depression Inventory, the Beck Anxiety Inventory, and Ten-Item Personality Inventory. An important finding in this study was that almost 57% ( n = 97) of men reported a psychiatric diagnosis and 28% ( n = 27) had a first-degree relative with a mental health disorder, of this group 17 only had a family history. Nearly 50% of the men surveyed reported clinically significant depression as evidenced by Beck Depression Inventory score and 34% experienced anxiety on the Beck Anxiety Inventory. There were no statistically significant trends in personality traits reported. Results provide evidence on the need to screen for psychiatric history and counseling patients about the potential psychological consequences of finasteride. Prescribing clinicians should carefully weigh the risk/benefit ratio with these patients.

Entities:  

Keywords:  androgenetic alopecia; finasteride; post-finasteride syndrome

Mesh:

Substances:

Year:  2016        PMID: 26868914      PMCID: PMC5734544          DOI: 10.1177/1557988316631624

Source DB:  PubMed          Journal:  Am J Mens Health        ISSN: 1557-9883


  30 in total

1.  Refining the relationship between personality and subjective well-being.

Authors:  Piers Steel; Joseph Schmidt; Jonas Shultz
Journal:  Psychol Bull       Date:  2008-01       Impact factor: 17.737

2.  Psychologic characteristics of men with alopecia androgenetica and their modification.

Authors:  J van der Donk; J Passchier; R O Dutree-Meulenberg; E Stolz; F Verhage
Journal:  Int J Dermatol       Date:  1991-01       Impact factor: 2.736

3.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

4.  Finasteride-induced depression: new insights into possible pathomechanisms.

Authors:  Benedikt Römer; Peter Gass
Journal:  J Cosmet Dermatol       Date:  2010-12       Impact factor: 2.696

Review 5.  The psychosocial consequences of androgenetic alopecia: a review of the research literature.

Authors:  T F Cash
Journal:  Br J Dermatol       Date:  1999-09       Impact factor: 9.302

6.  Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions.

Authors:  Umit Aydogan; Aydogan Aydogdu; Halil Akbulut; Alper Sonmez; Servet Yuksel; Yalcin Basaran; Ozcan Uzun; Erol Bolu; Kenan Saglam
Journal:  Endocr J       Date:  2012-08-31       Impact factor: 2.349

7.  Young men's coping with androgenetic alopecia: acceptance counts when hair gets thinner.

Authors:  Dirk Kranz
Journal:  Body Image       Date:  2011-08-19

8.  Psychiatric morbidity in dermatological outpatients: an issue to be recognized.

Authors:  A Picardi; D Abeni; C F Melchi; P Puddu; P Pasquini
Journal:  Br J Dermatol       Date:  2000-11       Impact factor: 9.302

9.  The psychological effects of androgenetic alopecia in men.

Authors:  T F Cash
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

10.  Alopecia areata: psychiatric comorbidity and adjustment to illness.

Authors:  Sergio Ruiz-Doblado; Ana Carrizosa; Maria Jose García-Hernández
Journal:  Int J Dermatol       Date:  2003-06       Impact factor: 2.736

View more
  9 in total

Review 1.  Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome.

Authors:  Raymond Fertig; Jerry Shapiro; Wilma Bergfeld; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2016-09-23

2.  Association of Suicidality and Depression With 5α-Reductase Inhibitors.

Authors:  Blayne Welk; Eric McArthur; Michael Ordon; Kelly K Anderson; Jade Hayward; Stephanie Dixon
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

3.  Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia.

Authors:  Mohit Khera; Jeffrey K Than; James Anaissie; Ali Antar; Weitao Song; Boriss Losso; Alexander Pastuszak; Taylor Kohn; Jorge Rivera Mirabal
Journal:  Transl Androl Urol       Date:  2020-06

4.  Results from the reduce trial on the effect of prostate size on incident lower urinary tract symptoms in men with mild to no current symptoms: do they justify prophylactic intervention?

Authors:  Marcus John Drake
Journal:  Transl Androl Urol       Date:  2016-10

5.  Post-finasteride syndrome: An emerging clinical problem.

Authors:  Silvia Diviccaro; Roberto Cosimo Melcangi; Silvia Giatti
Journal:  Neurobiol Stress       Date:  2019-12-26

6.  Research Brief: Self-Reports of a Constellation of Persistent Antiandrogenic, Estrogenic, Physical, and Psychological Effects of Finasteride Usage Among Men.

Authors:  Alicia A Walf; Shan Kaurejo; Cheryl A Frye
Journal:  Am J Mens Health       Date:  2018-01-10

7.  Depression risk associated with the use of 5α-reductase inhibitors versus α-blockers: A retrospective cohort study in South Korea.

Authors:  Bora Yeon; Ah Young Suh; Eunmi Choi; Bonggi Kim; Eunsun Noh; Soo Youn Chung; Soon Young Han
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

8.  The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli.

Authors:  Sean C Godar; Roberto Cadeddu; Gabriele Floris; Laura J Mosher; Zhen Mi; David P Jarmolowicz; Simona Scheggi; Alicia A Walf; Carolyn J Koonce; Cheryl A Frye; Nancy A Muma; Marco Bortolato
Journal:  Biomolecules       Date:  2019-11-19

Review 9.  Psychology's medicalization of male baldness.

Authors:  Glen S Jankowski; Hannah Frith
Journal:  J Health Psychol       Date:  2021-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.